Nanosonics Limited

ASX:NAN Stock Report

Market Cap: AU$898.5m

Nanosonics Valuation

Is NAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NAN (A$2.96) is trading below our estimate of fair value (A$5)

Significantly Below Fair Value: NAN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NAN?

Key metric: As NAN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NAN. This is calculated by dividing NAN's market cap by their current earnings.
What is NAN's PE Ratio?
PE Ratio69.3x
EarningsAU$12.97m
Market CapAU$898.50m

Price to Earnings Ratio vs Peers

How does NAN's PE Ratio compare to its peers?

The above table shows the PE ratio for NAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44.7x
SDI SDI
13.5x17.8%AU$140.3m
ANN Ansell
39x22.7%AU$4.8b
PGC Paragon Care
97.8x37.0%AU$819.4m
ACL Australian Clinical Labs
28.6x16.0%AU$685.1m
NAN Nanosonics
69.3x24.0%AU$898.5m

Price-To-Earnings vs Peers: NAN is expensive based on its Price-To-Earnings Ratio (69.3x) compared to the peer average (40.8x).

Price to Earnings Ratio vs Industry

How does NAN's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

9 CompaniesPrice / EarningsEstimated GrowthMarket Cap
NAN 69.3xIndustry Avg. 28.2xNo. of Companies46PE020406080100+
9 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NAN is expensive based on its Price-To-Earnings Ratio (69.3x) compared to the Global Medical Equipment industry average (28.2x).

Price to Earnings Ratio vs Fair Ratio

What is NAN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NAN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio69.3x
Fair PE Ratio39.2x

Price-To-Earnings vs Fair Ratio: NAN is expensive based on its Price-To-Earnings Ratio (69.3x) compared to the estimated Fair Price-To-Earnings Ratio (39.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$2.96
AU$3.46
+17.0%
11.2%AU$4.00AU$2.75n/a10
Dec ’25AU$3.26
AU$3.46
+6.2%
11.2%AU$4.00AU$2.75n/a10
Nov ’25AU$3.20
AU$3.53
+10.3%
12.1%AU$4.20AU$2.75n/a11
Oct ’25AU$3.69
AU$3.53
-4.4%
12.1%AU$4.20AU$2.75n/a11
Sep ’25AU$3.23
AU$3.48
+7.8%
12.5%AU$4.20AU$2.75n/a12
Aug ’25AU$3.20
AU$3.33
+4.2%
16.8%AU$4.20AU$2.55n/a12
Jul ’25AU$2.87
AU$3.20
+11.6%
16.4%AU$4.20AU$2.55n/a12
Jun ’25AU$2.81
AU$3.20
+14.0%
16.4%AU$4.20AU$2.55n/a12
May ’25AU$2.83
AU$3.20
+13.2%
16.4%AU$4.20AU$2.55n/a12
Apr ’25AU$2.75
AU$3.20
+16.5%
16.4%AU$4.20AU$2.55n/a12
Mar ’25AU$2.77
AU$3.20
+15.7%
16.4%AU$4.20AU$2.55n/a12
Feb ’25AU$2.90
AU$3.75
+29.3%
15.6%AU$5.00AU$2.83n/a11
Jan ’25AU$4.40
AU$4.56
+3.7%
14.7%AU$5.46AU$3.65n/a12
Dec ’24AU$4.11
AU$4.65
+13.2%
17.9%AU$6.50AU$3.65AU$3.2612
Nov ’24AU$3.86
AU$4.65
+20.5%
17.9%AU$6.50AU$3.65AU$3.2012
Oct ’24AU$4.22
AU$4.69
+11.2%
17.1%AU$6.50AU$3.75AU$3.6912
Sep ’24AU$4.15
AU$4.59
+10.6%
18.6%AU$6.50AU$3.34AU$3.2313
Aug ’24AU$4.78
AU$4.76
-0.3%
17.9%AU$6.50AU$3.34AU$3.2013
Jul ’24AU$4.74
AU$4.72
-0.4%
19.1%AU$6.50AU$3.34AU$2.8712
Jun ’24AU$5.17
AU$4.72
-8.6%
19.1%AU$6.50AU$3.34AU$2.8112
May ’24AU$5.54
AU$4.71
-15.0%
18.8%AU$6.50AU$3.34AU$2.8312
Apr ’24AU$5.09
AU$4.54
-10.7%
15.5%AU$6.00AU$3.34AU$2.7512
Mar ’24AU$4.46
AU$4.45
-0.2%
12.9%AU$5.35AU$3.34AU$2.7712
Feb ’24AU$4.81
AU$4.47
-7.0%
14.3%AU$5.50AU$3.25AU$2.9011
Jan ’24AU$4.29
AU$4.32
+0.7%
16.4%AU$5.50AU$3.25AU$4.4011
Dec ’23AU$4.84
AU$4.32
-10.7%
16.4%AU$5.50AU$3.25AU$4.1111

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 04:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nanosonics Limited is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Josh KannourakisBarrenjoey Markets Pty Limited
John HesterBell Potter